Literature DB >> 18989301

Angiogenesis factors and preeclampsia.

Ralf Dechend, Friedrich C Luft.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18989301     DOI： 10.1038/nm1108-1187

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.

Authors:  JoonHo Lee; Roberto Romero; Zhong Dong; Deug-Chan Lee; Yi Dong; Pooja Mittal; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

2.  Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.

Authors:  Jeffry Iman Gurnadi; Johannes Mose; Budi Handono; Mieke H Satari; Anita Deborah Anwar; Prima Nanda Fauziah; A Yogi Pramatirta; Dwi Davidson Rihibiha
Journal:  BMC Res Notes       Date:  2015-10-04

3.  Maternal heme oxygenase 1 regulates placental vasculature development via angiogenic factors in mice.

Authors:  Hui Zhao; Junya Azuma; Flora Kalish; Ronald J Wong; David K Stevenson
Journal:  Biol Reprod       Date:  2011-07-20       Impact factor: 4.285

Review 4.  [Side effect management of tyrosine kinase inhibitors in urology : Hypertension].

Authors:  D Sikic; N Meidenbauer; V Lieb; B Keck
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

5.  Corin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting. [Corrected].

Authors:  Ningzheng Dong; Tiantian Zhou; Yue Zhang; Meng Liu; Hui Li; Xiaoyi Huang; Zhenzhen Liu; Yi Wu; Koichi Fukuda; Jun Qin; Qingyu Wu
Journal:  J Biol Chem       Date:  2014-05-14       Impact factor: 5.157

6.  Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.

Authors:  Brian I Rini; Darrel P Cohen; Dongrui R Lu; Isan Chen; Subramanian Hariharan; Martin E Gore; Robert A Figlin; Michael S Baum; Robert J Motzer
Journal:  J Natl Cancer Inst       Date:  2011-04-28       Impact factor: 13.506

7.  Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group.

Authors:  Andrea Casadei Gardini; Emanuela Scarpi; Giorgia Marisi; Francesco Giuseppe Foschi; Gabriele Donati; Emanuela Giampalma; Luca Faloppi; Mario Scartozzi; Nicola Silvestris; Marcello Bisulli; Jody Corbelli; Andrea Gardini; Giuliano La Barba; Luigi Veneroni; Stefano Tamberi; Stefano Cascinu; Giovanni Luca Frassineti
Journal:  Oncotarget       Date:  2016-03-22

8.  Age-related Beta-synuclein Alters the p53/Mdm2 Pathway and Induces the Apoptosis of Brain Microvascular Endothelial Cells In Vitro.

Authors:  Katrin Brockhaus; Michael R R Böhm; Harutyun Melkonyan; Solon Thanos
Journal:  Cell Transplant       Date:  2018-05-29       Impact factor: 4.064

9.  A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia.

Authors:  Siqi Bao; Tong Zhou; Congcong Yan; Jiale Bao; Fan Yang; Shan Chao; Meng Zhou; Zhangye Xu
Journal:  BMC Med       Date:  2022-09-13       Impact factor: 11.150

10.  Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients.

Authors:  Frede Donskov; M Dror Michaelson; Igor Puzanov; Mellar P Davis; Georg A Bjarnason; Robert J Motzer; David Goldstein; Xun Lin; Darrel P Cohen; Robin Wiltshire; Brian I Rini
Journal:  Br J Cancer       Date:  2015-10-22       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.